AU7042994A - Recombinant (neu) differentiation factors - Google Patents

Recombinant (neu) differentiation factors

Info

Publication number
AU7042994A
AU7042994A AU70429/94A AU7042994A AU7042994A AU 7042994 A AU7042994 A AU 7042994A AU 70429/94 A AU70429/94 A AU 70429/94A AU 7042994 A AU7042994 A AU 7042994A AU 7042994 A AU7042994 A AU 7042994A
Authority
AU
Australia
Prior art keywords
neu
recombinant
differentiation factors
differentiation
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70429/94A
Inventor
Shaw-Fren Sylvia Hu
Raymond Allen Koski
Naili Liu
Glenn Francis Pierce
Barry J Sugarman
Duanzhi Wen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU7042994A publication Critical patent/AU7042994A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU70429/94A 1993-05-21 1994-05-23 Recombinant (neu) differentiation factors Abandoned AU7042994A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6638493A 1993-05-21 1993-05-21
US066384 1993-05-21
PCT/US1994/005769 WO1994028133A1 (en) 1993-05-21 1994-05-23 Recombinant neu differentiation factors

Publications (1)

Publication Number Publication Date
AU7042994A true AU7042994A (en) 1994-12-20

Family

ID=22069174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70429/94A Abandoned AU7042994A (en) 1993-05-21 1994-05-23 Recombinant (neu) differentiation factors

Country Status (2)

Country Link
AU (1) AU7042994A (en)
WO (1) WO1994028133A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670342A (en) * 1995-04-06 1997-09-23 Amgen Inc. NDF peptides
US5912326A (en) * 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
US5814308A (en) * 1996-03-26 1998-09-29 Zhang; Ke Methods for the treatment of gastrointestinal tract disorders
DE69732711T2 (en) * 1996-07-12 2006-03-16 Genentech, Inc., South San Francisco GAMMA-heregulin
DE69840699D1 (en) 1997-02-10 2009-05-14 Genentech Inc HEREGULIN VARIANTS
US6136558A (en) * 1997-02-10 2000-10-24 Genentech, Inc. Heregulin variants
WO1998056804A1 (en) * 1997-06-13 1998-12-17 Human Genome Sciences, Inc. 86 human secreted proteins
WO1999014323A1 (en) * 1997-09-17 1999-03-25 Urs Eppenberger Heregulin-gamma
US20010023241A1 (en) 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
US6017886A (en) * 1998-08-05 2000-01-25 Amgen Inc. Use of NDF peptide as growth factor for sensory epithelium
US6080845A (en) * 1998-08-05 2000-06-27 Amgen Inc. Monoclonal antibody against utricular epithelium
EP1259609A2 (en) * 2000-02-28 2002-11-27 Decode Genetics EHF. Human schizophrenia gene
AU2001241839A1 (en) * 2000-02-28 2001-09-12 Decode Genetics Ehf Human schizophrenia gene
SG10202109176RA (en) 2006-02-23 2021-09-29 Viacyte Inc Compositions and methods useful for culturing differentiable cells
NZ592622A (en) 2008-11-04 2012-10-26 Viacyte Inc Stem cell aggregate suspension compositions and methods for differentiation thereof
BR112012029611A2 (en) 2010-05-21 2017-07-25 Merrimack Pharmaceuticals Inc bispecific fusion protein, pharmaceutical composition, method of treating tissue damage in an individual, method of promoting tissue regeneration or survival in an individual, and nucleic acid molecule
CN103118698A (en) * 2010-05-28 2013-05-22 意识-Nrg公司 Neuregulin isoforms, neuregulin polypeptides and uses thereof
EP3974832A1 (en) 2011-10-06 2022-03-30 Aveo Pharmaceuticals, Inc. Predicting tumor response to anti-erbb3 antibodies
AU2013248265B2 (en) 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
WO2015158743A1 (en) * 2014-04-15 2015-10-22 Universiteit Antwerpen Treatment of nephropathy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1298392A (en) * 1991-03-17 1992-09-24 Yeda Research And Development Co. Ltd. Stimulating factor of the neu receptor
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
MX9302475A (en) * 1992-04-29 1994-05-31 Amgen Inc POLYPEPTIDE OF NON-NATURAL ORIGIN THAT HAS THE ACTIVITY OF THE RECOMBINANT FACTOR OF STIMULATION OF THE NEU RECEPTOR AND PROCESS FOR THE PRODUCTION OF MY MO.

Also Published As

Publication number Publication date
WO1994028133A1 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
AU7042994A (en) Recombinant (neu) differentiation factors
AU1398792A (en) Hybrid polypeptide
AU7043394A (en) Association peptides
AU4715493A (en) Peptide compounds
AU6475190A (en) Video cervicoscope
AU6034394A (en) Controlled lighting system
AU6360394A (en) Vasonatrin peptide and analogs thereof
AU4382193A (en) BPI-immunoglobulin fusion proteins
AU4838493A (en) Fusion glycoproteins
AU5283793A (en) Recombinant specific binding protein
AU6814694A (en) Videoconferencing system
AU3113493A (en) Video spectacles
AU7594594A (en) Slip-correcting load-clamping system
AU5500394A (en) Television projection system
AU4514193A (en) Bone formation-inducing protein
AU7036391A (en) Individualized video center
AU7031794A (en) Aircraft
GB9315303D0 (en) Polypeptide
AU6425394A (en) Sectional-bar system
AU4271793A (en) Novel polypeptide
AU5893394A (en) Aircraft
AU6715094A (en) Recombinant vaccine
AU6386094A (en) Switching system
AU6224194A (en) Blast-cleaning system
AU5927494A (en) Video adapter